Article
Identification of Trichomonas vaginalis 5-Nitroimidazole Resistance Targets
10 May 2023
Abstract excerpt
Trichomonas vaginalis is the most common non-viral sexually transmitted infection. 5-nitroimidazoles are the only FDA-approved medications for T. vaginalis treatment. However, 5-nitroimidazole resistance has been increasingly recognized and may occur in up to 10% of infections. We aimed to delineate mechanisms of T. vaginalis resistance using transcriptome profiling of metronidazole (MTZ)-resistant and sensitive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
